Axa »

Amneal Pharmaceuticals shares owned by Axa

Quarter-by-quarter ownership of Amneal Pharmaceuticals (AMRX) shares owned by Axa from 13F filings

Historical chart of Axa investment in Amneal Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Amneal Pharmaceuticals held by Axa consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Amneal Pharmaceuticals by Axa

Quarter filed Position value Share count Share price at filing
2024-03-31 $1.5M 239k 6.06

More positions owned by Axa

Microsoft Corporation (MSFT)
NVIDIA Corporation (NVDA)
Apple (AAPL)
Amazon (AMZN)
Alphabet Cap Stk Cl C (GOOG)
Alphabet Cap Stk Cl A (GOOGL)
Visa Com Cl A (V)
Broadcom (AVGO)
Stellantis SHS (STLA)
Intuitive Surgical Com New (ISRG)
UnitedHealth (UNH)
Meta Platforms Cl A (META)
Cadence Design Systems (CDNS)
Thermo Fisher Scientific (TMO)
Qualcomm (QCOM)

View all positions for Axa

Top funds holding Amneal Pharmaceuticals

Vanguard Group
Tpg Gp A
Fosun International
Rubric Capital Management
BlackRock
Citadel Advisors
Neuberger Berman Group
Dimensional Fund Advisors
Geode Capital Management
Nantahala Capital Management
Nuveen Asset Management
BlackBarn Capital Partners
Northern Trust
Charles Schwab Investment Management
LSV Asset Management

View all funds holding Amneal Pharmaceuticals